Tofacitinib Effective for Ankylosing Spondylitis in Phase 3 ...Middle East

Medscape - News
The oral JAK inhibitor was significantly more effective than placebo at primary and secondary endpoints. Safety risks were comparable to those seen in the treatment of rheumatoid and psoriatic arthritis. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Tofacitinib Effective for Ankylosing Spondylitis in Phase 3 )

Apple Storegoogle play

Also on site :